All comparisons

Educational Wellness Information Only

This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.

Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.

Immune comparison

ARA-290 vs Thymogen

An educational, source-based comparison of ARA-290 and Thymogen — how each peptide works, what it's researched for, and what to know before going deeper.

Neuropathic · Immune Modulation
ARA-290

Erythropoietin-derived peptide researched for neuropathy and tissue repair.

Mechanism

A synthetic 11-amino-acid peptide derived from the erythropoietin molecule. Research indicates it retains the tissue-protective (non-erythropoietic) effects of EPO via the β-common receptor, without stimulating red blood cell production.

Research areas
  • Small-fiber neuropathy and sarcoidosis
  • Diabetic neuropathy
  • Ischemia-reperfusion injury
  • Autoimmune modulation
Considerations
  • Investigational; not FDA-approved.
  • Does not raise hematocrit like full EPO molecule.
Full ARA-290 profile →
Immune · Bioregulator
Thymogen

Dipeptide bioregulator for immune system modulation.

Mechanism

A synthetic dipeptide (Glu-Trp) in the Khavinson bioregulator family. Research suggests modulation of thymic and immune cell gene expression, supporting T-cell maturation and innate immune response in aged models.

Research areas
  • Immunosenescence and age-related immune decline
  • Post-infectious immune recovery
  • Chronic fatigue and immune dysregulation
Considerations
  • Russian bioregulator research; limited independent replication.
  • Not FDA-approved.
Full Thymogen profile →

ARA-290 vs Thymogen — Key differences

  • Class: ARA-290 is classified as Neuropathic · Immune Modulation, while Thymogen is Immune · Bioregulator.
  • Primary research focus: ARA-290small-fiber neuropathy and sarcoidosis; Thymogenimmunosenescence and age-related immune decline.
  • Tag: Neuropathic pain · Immune vs Immune · Bioregulator.

Related comparisons